This might allow fine-tuning the benefit-to-side-effect ratio
Lancet 375:22342243 Marre M, Shaw J, Brndle M et al (2009) Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
Galactomyces is a nutrient-rich yeast ferment filtrate used widely in Asian skincare for its moisture-balancing, clarifying, and brightening properties
These agents simultaneously target multiple hormonal pathwaysGLP-1, GIP, glucagon, amylin, and othersto mimic the physiologic complexity of postprandial endocrine signaling, thereby offering a pharmacological surrogate for multisystemic benefits